Last reviewed · How we verify

NCT05369091: salivaryBMP2

Salivary Bmp-2 Levels & Radiographic Measurement Of Bone Density at Extracted Tooth

Completed Phase 4 Last updated 11 May 2022
What this trial tests

Phase 4 trial testing Simvastatin 10mg in Bone Injury in 24 participants. Completed in 5 January 2022.

Timeline
16 December 2020
Primary endpoint
3 October 2021
5 January 2022

Quick facts

Lead sponsorPostgraduate Medical Institute, Lahore
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment24
Start date16 December 2020
Primary completion3 October 2021
Estimated completion5 January 2022
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Postgraduate Medical Institute, Lahore

Who can join

Adults 18 to 25, any sex, with Bone Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Salivary Bmp-2 Levels \& Radiographic Measurement Of Bone Density were evaluated At Extracted Tooth Socket in patients With \& Without topical Application Of Simvastatin

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Simvastatin 10mg

Trials testing the same drug.

Other recruiting trials for Bone Injury

Currently open trials in the same condition.

Other Postgraduate Medical Institute, Lahore trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05369091.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing